HERMES INTERNATIONAL/ FR0000052292 /
09/05/2024 11:03:58 | Var. -28.00 | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
2,281.00EUR | -1.21% | 190 Fatturato: 433,323.50 |
-Quantità in denaro: - | -Quantità in lettera: - | 240.59 bill.EUR | 0.66% | 55.33 |
GlobeNewswire
11:06
Allot to Release First Quarter 2024 Earnings and Host Conference Call on May 29, 2024
GlobeNewswire
11:00
CN Moving to Kevric's Landmark Redevelopment at 600 De La Gauchetière Street West
GlobeNewswire
10:27
Chinese variety show "Ride the Wind 2024" is catapulting international talents onto the global stage
GlobeNewswire
10:00
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Inv...
GlobeNewswire
10:00
EQIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Equinix, Inc. Investors with S...
GlobeNewswire
10:00
ASTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AST SpaceMobile, Inc. Investor...
GlobeNewswire
10:00
LNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lincoln National Corporation In...
GlobeNewswire
10:00
CMP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Minerals International,...
GlobeNewswire
10:00
ADSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Autodesk, Inc. Investors with ...
GlobeNewswire
08:35
Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...